Medically Assisted Treatment program (MAT)

WhiteSands Treatment Tampa provides medication-assisted treatment (MAT) for opioid use disorder and alcohol use disorder at our Tampa facilities, offering methadone, Suboxone (buprenorphine/naloxone), buprenorphine formulations, and Vivitrol (monthly injectable naltrexone) as part of an integrated clinical program that combines medication with individual counseling, group therapy, and evidence-based behavioral treatment.

MAT at WhiteSands Tampa is available within our inpatient rehabilitation program at Hyde Park and our outpatient programs at Gunn Highway. It is not offered as a standalone prescription service. Call our Tampa admissions team at (813) 213-0442 to discuss which MAT option is clinically appropriate for your situation.

What Medication-Assisted Treatment for Opioid Use Disorder Involves

Medication-assisted treatment (MAT) for opioid use disorder combines FDA-approved medications that reduce cravings and withdrawal symptoms with individual counseling, group therapy, and behavioral treatment. MAT is the most evidence-supported clinical approach for opioid use disorder and is recommended as a first-line treatment by SAMHSA, the American Society of Addiction Medicine, and the National Institute on Drug Abuse.

MAT does not substitute one addiction for another. The medications used in MAT act on the same opioid receptors that heroin, fentanyl, and prescription opioids activate, but they do so in ways that stabilize brain chemistry, reduce cravings, and prevent the euphoric effects of opioids without producing the cycle of intoxication and withdrawal that characterizes active opioid use disorder. The goal of MAT is to restore normal neurological functioning so that the therapeutic work of counseling and behavioral change can proceed effectively.

MAT Medications Available at WhiteSands Tampa

Methadone

Methadone is a full opioid agonist that eliminates withdrawal symptoms and reduces cravings by activating the opioid receptors at a stable, controlled level without producing the euphoric spike associated with heroin or fentanyl use. Methadone maintenance treatment is one of the oldest and most extensively researched MAT approaches and has a decades-long evidence base for reducing opioid use, improving retention in treatment, and lowering overdose mortality.

Methadone for opioid use disorder is dispensed through WhiteSands Tampa’s federally certified treatment program. Patients receiving methadone maintenance attend the clinic for daily dispensing, particularly in the early phases of treatment, with take-home doses becoming available as treatment progresses and stability is established. Methadone maintenance is not a short-term intervention. For many patients, it is a long-term treatment that provides the neurological stability on which sustained recovery is built.

Suboxone (Buprenorphine/Naloxone)

Suboxone is a combination medication containing buprenorphine, a partial opioid agonist, and naloxone, an opioid antagonist included to deter injection misuse. Suboxone reduces opioid withdrawal symptoms and cravings through the partial agonist activity of buprenorphine, while the ceiling effect of buprenorphine reduces the risk of respiratory depression associated with full opioid agonists. Suboxone can be prescribed in an office-based setting, allowing for less frequent clinic visits than methadone maintenance once the patient is stabilized.

WhiteSands Tampa provides Suboxone treatment as part of the outpatient MAT program at Gunn Highway and within the inpatient program at Hyde Park, where clinically indicated. Suboxone treatment includes prescriber appointments, medication management, and integration with the full outpatient or inpatient clinical program.

Buprenorphine

Buprenorphine is available in several formulations at WhiteSands Tampa beyond the standard Suboxone tablet. Sublocade is a monthly injectable buprenorphine formulation that eliminates the need for daily oral dosing and removes the compliance variability associated with daily self-administered medications. For patients who want the clinical benefits of buprenorphine without the daily tablet dosing requirement, Sublocade provides the same medication in a once-monthly injection format administered by a healthcare provider.

Vivitrol (Monthly Injectable Naltrexone)

Vivitrol is the brand name for monthly injectable naltrexone, an opioid antagonist that blocks the euphoric and reinforcing effects of opioids, making relapse less rewarding and sustained sobriety more achievable. Unlike methadone and buprenorphine, naltrexone is not an opioid and produces no physical dependence. Patients must be fully detoxified from opioids before Vivitrol can be initiated, as naltrexone will precipitate acute withdrawal in opioid-dependent patients.

Vivitrol is also the most effective FDA-approved medication for alcohol use disorder, blocking the reward response to alcohol and reducing cravings in patients managing alcohol use disorder alongside or independently from opioid use disorder.

Naltrexone for Alcohol Use Disorder

Oral naltrexone for alcohol use disorder is available at WhiteSands Tampa as a daily tablet that reduces cravings and blocks the euphoric reward response to alcohol. For patients who prefer a longer-acting option, Vivitrol (monthly injectable naltrexone) provides the same mechanism in a once-monthly injection format that removes the daily compliance requirement.

Inpatient Methadone and MAT Treatment in Tampa

Most methadone clinics in Tampa provide standalone dispensing without an integrated rehabilitation program. WhiteSands Tampa offers something different: methadone and MAT integrated into a full inpatient rehabilitation program at our Hyde Park facility or outpatient program at Gunn Highway, combining the medical stabilization that MAT provides with the behavioral, psychological, and relational treatment that produces long-term recovery.

For patients who need inpatient methadone treatment in Tampa, WhiteSands Hyde Park provides medically supervised stabilization alongside the full residential rehabilitation program, including individual therapy, group therapy, CBT, dual diagnosis treatment for co-occurring mental health conditions, and the Life Skills programming that every inpatient patient receives throughout their stay.

The combination of methadone or Suboxone stabilization and intensive inpatient rehabilitation gives patients two things simultaneously: the neurological stability that MAT provides, and the behavioral and psychological treatment that addresses the underlying patterns of addiction. Research consistently demonstrates that MAT combined with counseling and behavioral therapy produces significantly better outcomes than MAT alone.

Alternatives to Methadone in Tampa: Suboxone, Vivitrol, and Buprenorphine

Not every patient with opioid use disorder is the right candidate for methadone maintenance, and many patients specifically request a non-methadone alternative when calling our Tampa admissions team. Methadone requires daily clinic attendance in the early treatment phase and is a full opioid agonist, which means some patients, particularly those with concerns about medication dependence or those whose circumstances make daily clinic visits impractical, are better served by Suboxone or Vivitrol.

WhiteSands Tampa provides both Suboxone and Vivitrol as alternatives to methadone for patients with opioid use disorder. Here is a straightforward clinical comparison:

  • Suboxone (buprenorphine/naloxone): partial opioid agonist, reduces withdrawal and cravings, can be prescribed in office-based settings with less frequent clinic visits than methadone, mild physical dependence develops, appropriate for patients who want effective opioid pharmacotherapy with more flexibility than methadone
  • Vivitrol (monthly injectable naltrexone): opioid antagonist, no opioid activity, no physical dependence, blocks euphoric effects of opioids and alcohol, requires complete detoxification before initiation, monthly injection format removes daily dosing requirement, appropriate for patients who are fully detoxified and want a non-opioid-based pharmacological support

The right choice between methadone, Suboxone, and Vivitrol depends on the severity of opioid dependence, the patient’s prior treatment history, their preferences, and their practical circumstances. Our Tampa admissions and clinical team discusses these options honestly with every patient before any treatment decision is made.

Methadone Maintenance Clinic in Tampa: What to Expect

Patients searching for methadone maintenance in Tampa are looking for the specific ongoing treatment format in which methadone is dispensed regularly as part of a structured clinical relationship. At WhiteSands Tampa, methadone maintenance is integrated with counseling and clinical treatment rather than offered as a dispensing-only service.

In the early phase of methadone maintenance treatment at WhiteSands Tampa, patients attend the clinic for observed daily dosing while the therapeutic dose is established and stabilized. As treatment progresses and the patient demonstrates clinical stability and engagement, take-home doses become available according to federal program guidelines, reducing the required clinic attendance. Ongoing counseling and clinical contact continue throughout the maintenance phase, addressing the behavioral and psychological dimensions of recovery alongside the medication component.

Buprenorphine Clinic in Tampa: Suboxone Doctors and Prescribers

Patients searching for a buprenorphine clinic in Tampa or Suboxone doctors in Tampa are looking for a licensed prescriber who can initiate and manage Suboxone or buprenorphine treatment as part of an office-based opioid treatment program. WhiteSands Tampa provides buprenorphine prescribing and management through licensed prescribers within our outpatient program at Gunn Highway.

Suboxone treatment at WhiteSands Tampa is not a prescribe-and-discharge service. Suboxone or buprenorphine prescribing is integrated with individual counseling, group therapy, and the full outpatient clinical program. Patients who want Suboxone as part of a structured outpatient treatment program rather than a standalone prescription service will find the WhiteSands Tampa approach matches that clinical standard.

Insurance Coverage for MAT in Tampa

Most private insurance plans cover medication-assisted treatment for opioid use disorder and alcohol use disorder as medically necessary under the Mental Health Parity and Addiction Equity Act. Coverage typically extends to the cost of the medication itself (methadone, Suboxone, Vivitrol), prescriber appointments and medication management, and the counseling and behavioral therapy components of the MAT program.

WhiteSands Treatment Tampa accepts Florida Blue, United Healthcare, Aetna, Cigna, Humana, Anthem Blue Cross Blue Shield, and most PPO plans. TRICARE is accepted for eligible veterans and military. Our admissions team verifies insurance benefits for MAT at no cost before any admission decision. Call (813) 213-0442 with your member ID.

Medication-assisted treatment is not a shortcut or a lesser form of addiction treatment. It is one of the most effective clinical tools available for opioid use disorder, and when combined with counseling and behavioral therapy as it is at WhiteSands Tampa, it produces outcomes that medication alone or therapy alone cannot match. Whether you are looking for methadone maintenance, Suboxone treatment, buprenorphine, or Vivitrol in Tampa, our clinical team will help you understand which option makes the most sense for your specific situation.

DR. S. MANN, M.D., CHIEF MEDICAL OFFICER, WHITESANDS TREATMENT CENTER

Dr. Mann currently serves as the Chief Medical Officer and Medical Director of the WhiteSands Treatment Centers, and he has held these positions since July 2017. In addition to medical department administrative duties, Dr. Mann is responsible for the medical needs and detoxification of patients at WhiteSands Treatment, Tampa.

Before joining WhiteSands, Dr. Mann had worked in addiction treatment facilities throughout Florida. He has served as an Adjunct Clinical Postdoctoral Associate in the Addiction Medicine Division at the University of Florida, where he enjoyed teaching medical students and medical school graduates during their residency training. He has also practiced Addiction Medicine in the private sector and served as both Medical Director and Associate Medical Director at other substance abuse treatment centers. He currently enjoys both clinical duties and oversight roles as Medical Director of WhiteSands Treatment Centers. Dr. Mann appreciates the teamwork at WhiteSands and how this helps patients resume a happy, fulfilling life.

Dr. Mann graduated with honors from Indiana University, where he earned both his Medical Degree and a degree in chemistry. He completed his internship at the University of Miami-Jackson Memorial Hospital before completing his residency in Internal Medicine at Mount Sinai Medical Center in Miami Beach, FL. He later studied Addiction Counseling in Denver, Colorado, and he completed an Addiction Medicine Fellowship in the Psychiatry Department at the University of Florida. Dr. Mann is Board-Certified in his field.

, ATTENDING PHYSICIAN, WHITESANDS TREATMENT CENTER

Dr. Kirby joined WhiteSands Treatment in 2018 as an attending physician. He brings with him many years of experience in internal medicine and addiction medicine practice. Before joining WhiteSands Treatment, Dr. Kirby spent several years working with the men enrolled in the Salvation Army rehabilitation program and with students who were seeking help through the Teen Challenge Restoration Program. Dr. Kirby is well-versed in medical science as it pertains to addiction. He also has a special interest in the spirituality of recovery from addictions. He has served as an Adjunct Clinical Postdoctoral Associate in the Addiction Medicine Division at the University of Florida, where he enjoyed teaching medical students and medical school graduates during their residency training.

Dr. Kirby received his B.S. in Biology with Honors from the University of Missouri, Kansas City, and was granted a Doctor of Medicine from the School of Medicine here. He completed a residency in Internal Medicine at Wilford Hall Medical Center in San Antonio, Texas. After serving as a captain in the USAF, he entered the private practice of internal medicine. He later felt called to help people overcome their addictions, which led him into the addiction treatment sector. He completed an Addiction Medicine Fellowship in the Psychiatry Department at the University of Florida before joining WhiteSands. Dr. Kirby is a Fellow of the American Society of Addiction Medicine. He is board-certified in both Internal Medicine and Addiction Medicine.